Author:
Chen Rong,Liu Hengfang,Meng Weikang,Sun Jingyu
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Shallis, R. M., Wang, R., Davidoff, A., Ma, X. & Zeidan, A. M. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Rev. 36, 70–87 (2019).
2. Madanat, Y. F., Kalaycio, M. E. & Nazha, A. Advances in acute myeloid leukemia genomics, where do we stand in 2018?. Acta Med. Acad. 48(1), 35–44 (2019).
3. Greiner, J., Götz, M. & Wais, V. Increasing role of targeted immunotherapies in the treatment of AML. Int. J. Mol. Sci. 23(6), 3304 (2022).
4. Martínez-Cuadrón, D. et al. Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: Changing everything to change nothing?. Leukemia 35(6), 1571–1585 (2021).
5. Yang, G. X. et al. Advanced natural products chemistry research in China between 2015 and 2017. Chin. J. Nat. Med. 16(12), 881–906 (2018).